Clinical Trials List
2022-10-01 - 2030-05-31
Phase III
Recruiting5
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- 陳珈妤 Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Yu-Min Liao Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ping Chen 未分科
- Chun-Hui Lee 未分科
- Ya-Ting Hsu 未分科
- 顏志傑 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chieh-Lin Teng 未分科
- HSIN-CHEN LIN Division of Hematology & Oncology
- 滕傑林 Division of Hematology & Oncology
- Tsung -Chih Chen 未分科
- 陳文賢 Division of Hematology & Oncology
- CHENG-HSIEN LIN Division of Hematology & Oncology
- PO-WEI LIAO Division of Hematology & Oncology
- YU-HSUAN SHIH Division of Hematology & Oncology
- 陳虹潔 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yao-Chung Liu 未分科
- 陳玟均 未分科
- Po-Shen Ko 未分科
- Sheng-Hsuan Chien 未分科
- Chia-Jen Liu 未分科
- 蔡淳光 未分科
- 吳嘉紘 未分科
- Liang-Tsai Hsiao 未分科
- Ting-An Lin 未分科
- 陳蓉宣 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
500 participants
